Dark

QNRX
Quoin Pharmaceuticals, Ltd.
stock NASDAQ ADR

At Close

Aug 28, 2026 3:59:47 PM EDT

6.13USD+18.914%(+0.98)31,016,956

0.00Bid 0.00Ask 0.00Spread

Pre-market

Aug 28, 2026 9:29:59 AM EDT

7.26USD+40.834%(+2.11)2,001,623

After-hours

Aug 28, 2026 4:59:30 PM EDT

5.88USD-4.078%(-0.25)83,229

OverviewHistoricalExchangesShortsMore

open chart

Market Cap

12.25M

Headquarters

23 Hataas St, Kfar Sava, Israel

Industry

Biotechnology

Last Split

Apr 9, 20251for35reverse

QNRX Stats

Avg. Vol. 10 Day

3,123,855

Avg. Vol. 30 Day

1,053,542

Market Cap

12,249,542

Shares Out.

2,008,418

On/Off Exchange

52%/48%

6 Month Beta

1.12

1 Year Beta

-2.39

2 Year Beta

-0.78

3 Year Beta

-0.66

52 Week Low

3.25

52 Week High

41.80

SMA50

4.67

SMA200

8.12

1 Week

+9.50%

1 Month

+42.67%

3 Month

+20.54%

6 Month

-28.41%

1 Year

-17.30%

2 Year

-70.76%

5 Year

-100.00%

Profile

cellect biotechnology was founded in 2011 with a mission to become a global leader in the next generation of cellular therapies by developing innovative solutions for immune system regeneration. achieving higher selectivity, greater specificity and decreased toxicity, cellect envisions its products becoming an integral and essential part of bone marrow transplantation (bmt), as well as integrated into many aspects of regenerative medicine.

QNRX Stock Summary

Quoin Pharmaceuticals, Ltd. (NASDAQ:QNRX) stock price today is $6.13, and today's volume is 31,016,956. QNRX is up 18.914% today. The 30 day average volume is 1,053,542. QNRX market cap is 12.25M with 2,008,418 shares outstanding.

.dark-mode .XXsWjM{ color: white; background-color: #333333; border: 2px solid white; }.light-mode .XXsWjM{ color: #333333; background-color: white; border: 2px solid #333333; }QNRXQuoin Pharmaceuticals, Ltd.stock NASDAQ ADR

QNRX Stock Summary

QNRX
Quoin Pharmaceuticals, Ltd.
stock NASDAQ ADR